These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 10566724

  • 1. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine.
    Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW.
    Am J Gastroenterol; 1999 Nov; 94(11):3248-53. PubMed ID: 10566724
    [Abstract] [Full Text] [Related]

  • 2. Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease.
    Korelitz BI, Fuller SR, Warman JI, Goldberg MD.
    Am J Gastroenterol; 1999 Feb; 94(2):424-6. PubMed ID: 10022640
    [Abstract] [Full Text] [Related]

  • 3. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS, Zlatanic J, Korelitz BI, Gleim GW.
    Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
    [Abstract] [Full Text] [Related]

  • 4. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J, Grancher K, Mandel F, Daum F.
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [Abstract] [Full Text] [Related]

  • 5. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
    Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, Bak Andersen I, Wewer V, Nørregaard P, Moesgaard F, Bendtsen F, Munkholm P, DCCD study group.
    Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949
    [Abstract] [Full Text] [Related]

  • 6. Inflammatory bowel disease in Iran: a review of 457 cases.
    Aghazadeh R, Zali MR, Bahari A, Amin K, Ghahghaie F, Firouzi F.
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1691-5. PubMed ID: 16246187
    [Abstract] [Full Text] [Related]

  • 7. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC, Pintoffl JP, Sturm A, Wiedenmann B, Dignass AU.
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [Abstract] [Full Text] [Related]

  • 8. Are patients with inflammatory bowel disease receiving optimal care?
    Reddy SI, Friedman S, Telford JJ, Strate L, Ookubo R, Banks PA.
    Am J Gastroenterol; 2005 Jun; 100(6):1357-61. PubMed ID: 15929770
    [Abstract] [Full Text] [Related]

  • 9. Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease.
    Ansari A, Patel N, Sanderson J, O'Donohue J, Duley JA, Florin TH.
    Aliment Pharmacol Ther; 2010 Mar; 31(6):640-7. PubMed ID: 20015102
    [Abstract] [Full Text] [Related]

  • 10. Incidence of neoplasms in patients who develop sustained leukopenia during or after treatment with 6-mercaptopurine for inflammatory bowel disease.
    Disanti W, Rajapakse RO, Korelitz BI, Panagopoulos G, Bratcher J.
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1025-9. PubMed ID: 16765651
    [Abstract] [Full Text] [Related]

  • 11. Neuroendocrine neoplasms arising in inflammatory bowel disease: a report of 14 cases.
    Sigel JE, Goldblum JR.
    Mod Pathol; 1998 Jun; 11(6):537-42. PubMed ID: 9647591
    [Abstract] [Full Text] [Related]

  • 12. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J.
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [Abstract] [Full Text] [Related]

  • 13. Immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Hibi T, Iwao Y, Yajima T, Inoue N, Ueno Y, Takaishi H, Watanabe M, Ishii H.
    J Gastroenterol; 1995 Nov; 30 Suppl 8():121-3. PubMed ID: 8563872
    [Abstract] [Full Text] [Related]

  • 14. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
    Summers RW, Elliott DE, Qadir K, Urban JF, Thompson R, Weinstock JV.
    Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
    [Abstract] [Full Text] [Related]

  • 15. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH, Vermeire S, Christodoulou DK, Riis L, Wolters F, Odes S, Freitas J, Hoie O, Beltrami M, Fornaciari G, Clofent J, Bodini P, Vatn M, Nunes PB, Moum B, Munkholm P, Limonard C, Stockbrugger R, Rutgeerts P, Tsianos EV, EC-IBD Study Group.
    Digestion; 2007 Sep; 75(2-3):113-21. PubMed ID: 17598963
    [Abstract] [Full Text] [Related]

  • 16. [Epidemiology of inflammatory bowel diseases in Veszprém county of Western Hungary between 1977 and 2001].
    Lakatos L, Mester G, Erdélyi Z, Balogh M, Szipócs I, Kamarás G, Lakatos PL.
    Orv Hetil; 2003 Sep 14; 144(37):1819-27. PubMed ID: 14596020
    [Abstract] [Full Text] [Related]

  • 17. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.
    Scand J Gastroenterol; 2009 Sep 14; 44(1):46-55. PubMed ID: 18609187
    [Abstract] [Full Text] [Related]

  • 18. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
    Lees CW, Maan AK, Hansoti B, Satsangi J, Arnott ID.
    Aliment Pharmacol Ther; 2008 Feb 01; 27(3):220-7. PubMed ID: 17988235
    [Abstract] [Full Text] [Related]

  • 19. Cancer in inflammatory bowel disease.
    Greenstein AJ.
    Mt Sinai J Med; 2000 May 01; 67(3):227-40. PubMed ID: 10828908
    [Abstract] [Full Text] [Related]

  • 20. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun 01; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.